
Sign up to save your podcasts
Or


Host Jim Fries speaks to Ann Jordan, CEO of The American Society of Quality (ASQ), about recent changes in quality management since the COVID-19 pandemic. Ann discusses how these quality changes impact supply chain and data integrity in the pharmaceutical industry, and how quality professionals adapt and react to challenges in the workforce, technology, and risk management.
By Rx-360Host Jim Fries speaks to Ann Jordan, CEO of The American Society of Quality (ASQ), about recent changes in quality management since the COVID-19 pandemic. Ann discusses how these quality changes impact supply chain and data integrity in the pharmaceutical industry, and how quality professionals adapt and react to challenges in the workforce, technology, and risk management.